PJ Stone, MW Konstan, M Berger, HL Dorkin, C Franzblau and GL Snider
Department of Biochemistry, Boston University School of Medicine, Massachusetts 02118, USA.

Elastin degradation has been reported to be increased in patients with cystic fibrosis (CF). In order to further explore evidence for elastin degradation in a group of 18 patients with CF with a wide range of disease severity, we used an isotope dilution method to measure urinary desmosine (DES) and isodesmosine (IDES), amino acids derived exclusively from cross-linked elastin, and hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP), amino acids derived exclusively from cross-linked collagen. Urinary DES and IDES (mean +/- SD) were 23.9 +/- 30.7 and 18.5 +/- 22.4 micrograms/g creatinine, respectively, in the patients with CF versus 7.5 +/- 1.7 and 6.8 +/- 1.4 micrograms/g creatinine, respectively, in 10 healthy control subjects (p < 0.001); only two patients with CF had DES values within the control range. The values of urinary HP and LP in the CF group were 54.9 +/- 39.1 and 12.3 +/- 8.6 nmol/mmol creatinine, respectively, versus 24.5 +/- 5.8 and 5.1 +/- 2.7 nmol/mmol creatinine, respectively, in the controls (p < 0.005). Both HP and LP were highly correlated (r = 0.71, p < 0.0001). Patients with CF had active pulmonary inflammation; neutrophils were abundant in the bronchoalveolar lavage fluid of the CF group and correlated with elastase activity measured with methoxysuccinyl Ala-Ala- Pro-Val paranitroanilide (r = 0.61, p < 0.05). Airway neutrophils had decreased expression of the complement receptor CR1 (CR1/CR3 of 0.17 +/- 0.15 versus 1.0 for blood neutrophils), a change known to be caused by uninhibited neutrophil elastase. We conclude that lung elastin is the most likely source of the increased DES and IDES in CF.

This article has been cited by other articles:

				M. Luisetti, S. Ma, P. Iadarola, P. J. Stone, S. Viglio, B. Casado, Y. Y. Lin, G. L. Snider, and G. M. Turino Desmosine as a biomarker of elastin degradation in COPD: current status and future directions Eur. Respir. J., November 1, 2008; 32(5): 1146 - 1157. [Abstract] [Full Text] [PDF]

				T. N Hilliard, N. Regamey, J. K Shute, A. G Nicholson, E. W F W Alton, A. Bush, and J. C Davies Airway remodelling in children with cystic fibrosis Thorax, December 1, 2007; 62(12): 1074 - 1080. [Abstract] [Full Text] [PDF]

				S. D. Sagel, J. F. Chmiel, and M. W. Konstan Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417. [Abstract] [Full Text] [PDF]

				D. E. McClintock, B. Starcher, M. D. Eisner, B. T. Thompson, D. L. Hayden, G. D. Church, M. A. Matthay, and the National Heart, Lung, Blood Institute Acute Re Higher urine desmosine levels are associated with mortality in patients with acute lung injury Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L566 - L571. [Abstract] [Full Text] [PDF]

				P D Sly and S Brennan Detecting early lung disease in cystic fibrosis: are current techniques sufficient? Thorax, December 1, 2004; 59(12): 1008 - 1010. [Full Text] [PDF]

				S. Ma, S. Lieberman, G. M. Turino, and Y. Y. Lin The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum PNAS, October 28, 2003; 100(22): 12941 - 12943. [Abstract] [Full Text] [PDF]

				V. De Rose Mechanisms and markers of airway inflammation in cystic fibrosis Eur. Respir. J., February 1, 2002; 19(2): 333 - 340. [Abstract] [Full Text] [PDF]

				H. W. Vesper, L. M. Demers, R. Eastell, P. Garnero, M. Kleerekoper, S. P. Robins, A. K. Srivastava, G. R. Warnick, N. B. Watts, and G. L. Myers Assessment and Recommendations on Factors Contributing to Preanalytical Variability of Urinary Pyridinoline and Deoxypyridinoline Clin. Chem., February 1, 2002; 48(2): 220 - 235. [Abstract] [Full Text] [PDF]

				S Brennan, D Cooper, and P D Sly Directed neutrophil migration to IL-8 is increased in cystic fibrosis: a study of the effect of erythromycin Thorax, January 1, 2001; 56(1): 62 - 64. [Abstract] [Full Text]

				A. M. Tager, J. Wu, and M. W. Vermeulen The Effect of Chloride Concentration on Human Neutrophil Functions: Potential Relevance to Cystic Fibrosis Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 643 - 652. [Abstract] [Full Text]

				I. DURIEU, S. PEYROL, D. GINDRE, G. BELLON, D. V. DURAND, and Y. PACHECO Subepithelial Fibrosis and Degradation of the Bronchial Extracellular Matrix in Cystic Fibrosis Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 580 - 588. [Abstract] [Full Text] [PDF]

				K. C. MEYER and A. SHARMA Regional Variability of Lung Inflammation in Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1536 - 1540. [Abstract] [Full Text]